The detention of several AstraZeneca employees and eventually the company’s China president Leon Wang unsettled investors, fueling fears of a crackdown similar to the GSK scandal 10 years ago.
AstraZeneca has voluntarily withdrawn its marketing authorisation application to the European Medicines Agency (EMA) for datopotamab deruxtecan (Dato-DXd), an experimental precision drug for the ...
Achilles Therapeutics signs $12M deal with AstraZeneca for TRACERx data and tumor samples from lung cancer study. The company plans job cuts and Board reductions after completing its strategic ...
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of AstraZeneca PLC (NASDAQ: AZN) between February 23 ...
U.K.-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) is making news, but not in a good way. Its operations in China were recently rocked when Leon Wang, the company's president in the country ...
Learn More. The AstraZeneca (LSE:AZN) share price has been dragged down by several factors in recent months. Sub-optimal clinical trial results for its lung cancer treatment, Dato-DXd, raised ...
Beijing’s mayor called on AstraZeneca Plc to expand its research and development investment in the Chinese capital, signaling that a probe against some of its executives won’t affect business ...
AstraZeneca received “unfair flak” for its Covid vaccine, Matt Hancock has said. Mr Hancock, the former health secretary, was in office during the pandemic when the AstraZeneca vaccine was ...
BBC North West's Health Correspondent Gill Dummigan went to Macclesfield District General, which is one of the hospitals which is being helped. It's mid-morning in A&E at Macclesfield District ...